lobbying_activities: 756756

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
756756	8c893a3c-af3b-4759-a29a-5e890c8df6cb	Q1	APOTEX CORP.	310973	APOTEX CORP.	2009	first_quarter	PHA	S. 369, the Preserve Access to Affordable Generics Act HR 1706, the Protecting Consumer Access to Generic Drugs Act HR 1427, the Promoting Innovation and Access to Life Saving Medicine Act S. 726, the Promoting Innovation and Access to Life Saving Medicine Act HR 1548, Pathway for Biosimilars Act S. 501, the Fair Prescription Drug Competition Act HR 573 concerning authorized generics	Federal Trade Commission (FTC),HOUSE OF REPRESENTATIVES,SENATE		130000	0	0	2009-04-17T13:00:41-04:00